ASP Isotopes Inc. has announced its expected commencement of a dual listing on the Johannesburg Stock Exchange (JSE) under the abbreviated name "ASPI," with trading expected to begin on August 27, 2025. This comes as the JSE has approved the listing of the company's common stock on its main board.
The company also provided an update on its intention to acquire Renergen Limited, with Renergen shareholders having approved the resolution relating to the approval of the scheme at the general meeting held on July 10, 2025. The implementation of the scheme, however, remains subject to the fulfillment of the remaining offer conditions, which the company expects to occur during the third quarter of 2025.
ASP Isotopes Inc. aims to create a global leader in the production of critical materials, including electronic gases such as helium, various fluorinated products, and isotopically enriched gases, through the combination of the two businesses. The transaction is expected to be highly accretive to ASP's revenue, EBITDA, earnings per share, and cash flow per share during 2026, with the goal of generating over $300 million in EBITDA in 2030.
The company's Chairman and CEO, Paul Mann, expressed gratitude to the South African people for their support, emphasizing that the company's securities will now be available on the JSE.
As part of the announcement, the company revealed the appointment of Valeo Capital Proprietary Limited as the sole South African corporate advisor and JSE sponsor for the listing.
Additionally, in connection with the appointment of Donald Ainscow as Executive Vice President, General Counsel, and Secretary, the company granted him an award of restricted stock covering 400,000 shares of the company's common stock. Another non-executive employee was also granted an award of restricted stock covering 30,000 shares of the company's common stock.
ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries, with a focus on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The company employs proprietary technology, the aerodynamic separation process ("ASP technology"), and has isotope enrichment facilities in Pretoria, South Africa.
Following these announcements, the company's shares moved -2.32%, and are now trading at a price of $9.455. If you want to know more, read the company's complete 8-K report here.
